Enterprise Financial Services Corp Takeda Pharmaceutical CO LTD Transaction History

Enterprise Financial Services Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$16.3 - $17.26 $19,201 - $20,332	-1,178 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$16.55 - $18.64 $2,780 - $3,131	168 Added 16.63%	1,178 $20,000
Q1 2021 May 13, 2021	BUY	$16.71 - $19.9 $2,940 - $3,502	176 Added 21.1%	1,010 $19,000
Q4 2020 Feb 12, 2021	SELL	$15.39 - $18.97 $892 - $1,100	-58 Reduced 6.5%	834 $15,000
Q3 2020 Nov 13, 2020	SELL	$17.1 - $19.19 $495 - $556	-29 Reduced 3.15%	892 $16,000

Q2 2020 Aug 04, 2020	BUY	$14.59 - $19.5 $7,470 - $9,984	512 Added 125.18%	921 $17,000
Q1 2020 May 15, 2020	SELL	$13.02 - $20.31 $7,004 - $10,926	-538 Reduced 56.81%	409 $6,000
Q4 2019 Jan 28, 2020	BUY	$16.88 - $20.83 $7,258 - $8,956	430 Added 83.17%	947 $18,000
Q3 2019 Oct 31, 2019	BUY	$16.15 - $17.99 $3,262 - $3,633	202 Added 64.13%	517 $9,000
Q2 2019 Jul 30, 2019	SELL	$16.58 - $20.49 $4,062 - $5,020	-245 Reduced 43.75%	315 $5,000
Q1 2019 Apr 26, 2019	BUY	$16.7 - $21.52 $9,185 - $11,836	550 Added 5500.0%	560 $11,000
Q4 2018 Jan 25, 2019	BUY	$15.64 - $21.1 $156 - $211	10 New	10 $0

338

76.2M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.5B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.